Cite
HARVARD Citation
Nash, P. et al. (n.d.). THU0448 Secukinumab for The Treatment of Psoriatic Arthritis: Comparative Effectiveness Results versus Adalimumab Up To 48 Weeks Using A Matching-Adjusted Indirect Comparison. Annals of the rheumatic diseases. pp. 353-354. [Online].